|
Volumn 36, Issue 4, 2007, Pages 262-263
|
Toxoplasmic Chorioretinitis and Antitumor Necrosis Factor Treatment in Rheumatoid Arthritis
|
Author keywords
anti TNF therapy; rheumatoid arthritis; toxoplasmic chorioretinitis
|
Indexed keywords
ADALIMUMAB;
ETANERCEPT;
FOLINIC ACID;
INFLIXIMAB;
LEFLUNOMIDE;
METHOTREXATE;
PREDNISONE;
PYRIMETHAMINE;
SULFADIAZINE;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ADULT;
ARTICLE;
CASE REPORT;
CHORIORETINITIS;
DRUG SUBSTITUTION;
FEMALE;
HUMAN;
INFECTION RISK;
MALE;
OPHTHALMOSCOPY;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
TOXOPLASMA GONDII;
TOXOPLASMOSIS;
VISUAL IMPAIRMENT;
ADULT;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CHORIORETINITIS;
FEMALE;
HUMANS;
MALE;
TOXOPLASMA;
TOXOPLASMOSIS, OCULAR;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 33846575210
PISSN: 00490172
EISSN: None
Source Type: Journal
DOI: 10.1016/j.semarthrit.2006.08.004 Document Type: Article |
Times cited : (58)
|
References (7)
|